Tag: Diabetes Management
-
Beyond weight loss: Semaglutide cuts heart risk faster than the scale moves
Introduction: A drug with dual promise Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has long been a staple in the toolbox for managing type 2 diabetes and supporting weight loss. But a growing body of evidence suggests its benefits extend beyond body mass, targeting cardiovascular risk in meaningful ways. The SELECT trial, in particular, has…
-
Study Warns of Hidden Risks in Popular Sugar Substitutes, Alternatives
New findings stir debate over sugar substitutes A new study published in a leading scientific journal raises fresh questions about the safety of widely used sugar substitutes, focusing on sorbitol, a common ingredient in many “sugar-free” products. While these substitutes have long been touted as healthier alternatives to sugar, researchers caution that their effects on…
-
Nutrition and Chronic Diseases: Practical Diet Strategies
Understanding the Link Between Nutrition and Chronic Diseases Chronic diseases such as heart disease, type 2 diabetes, obesity, and certain cancers are major drivers of death and disability in the United States. While genetics and environment play important roles, nutrition remains the largest modifiable factor individuals can adjust. A diet rich in whole foods, fiber,…
-
Ozempic-Like Drugs and Anesthesia: Why Some Surgeries Are Being Delayed
Understanding the rising concern: GLP-1 agonists and anesthesia Glucagon-like peptide-1 (GLP-1) receptor agonists, including popular medications such as Ozempic (semaglutide), are increasingly prescribed for type 2 diabetes and obesity. While these drugs offer meaningful benefits in controlling blood sugar and promoting weight loss, they can present unique challenges when a patient needs anesthesia for surgery.…
-
A Letter of Hope: A Diabetes Patient’s Dream of Motherhood and an Artificial Pancreas
Hope in a Letter: A Dream of Motherhood with Type 1 Diabetes In a deeply personal note, a woman living with Type 1 diabetes has shared her dream of becoming a mother through a heartfelt letter to her future child. The piece, described by the author as a “great act of hope,” shines a light…
-
Diabetes Awareness Month: Education for Everyone—FNHA Highlights Community Stories
Diabetes Awareness Month 2025: Education for Everyone Each November, Diabetes Awareness Month shines a light on the importance of education, screening, and ongoing support to prevent and manage diabetes. This year, the First Nations Health Authority (FNHA) invites communities to learn from each other and recognize that education is for everyone—across ages, cultures, and regions.…
-
GLP-1 Medications and Pregnancy: Interpreting Early Signals and Risks
Understanding GLP-1 Medications and Pregnancy GLP-1 receptor agonists, such as Ozempic (semaglutide), are widely prescribed for type 2 diabetes and some cases of obesity treatment. They work by mimicking an incretin hormone that helps regulate blood sugar and appetite. When considering pregnancy, however, medical guidance has historically recommended avoiding GLP-1 medications because of potential risks…
-
GLP-1 Drugs and Pregnancy: Early Signals of Risk But With Caveats
Overview: GLP-1 medications and pregnancy Glucagon-like peptide-1 (GLP-1) receptor agonists, including Ozempic (semaglutide) and similar drugs, are widely used for type 2 diabetes and obesity treatment. Recent studies have explored potential links between GLP-1 use and pregnancy outcomes. The emerging signals are not definitive, and experts emphasize cautious interpretation. The key takeaway is that these…
-
GLP-1 Medications and Pregnancy: Early Signals, Important Caveats
Overview: GLP-1 Drugs and Pregnancy Concerns Glucagon-like peptide-1 (GLP-1) receptor agonists, including popular medications like Ozempic, are widely used to manage type 2 diabetes and support weight loss. Recent studies have raised questions about potential pregnancy-related risks for people taking these drugs. However, researchers stress that the data are preliminary, come with important caveats, and…
-
Improving the Lives of People with Diabetes: Expanding Access to Life-Changing Technologies
Expanding Access to Advanced Diabetes Technologies In a decisive move to improve the everyday lives of people living with diabetes, Scotland is increasing access to state-of-the-art technologies. An additional 2,500 individuals with type 1 diabetes will benefit from innovative tools designed to prevent serious health complications and enhance overall well-being. This initiative is supported by…